| Business Name: |
Providence Regional Cancer |
| Contact Person: |
Buffie Salo, Office Manager |
| Address: |
4525 3rd Avenue Se # 200, Lacey, Washington 98503 |
| Phone Number: |
(360) 754-3934 |
| Annual Revenue (USD): |
$10.000.000 to $19.9999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Ritland Sandra MD - Lacey, WA 98503
Pratt David V MD - Lacey, WA 98503
Allen Gregory W MD - Lacey, WA 98503
Krauss Ronald MD - Lacey, WA 98503
Rudd Jay C MD - Lacey, WA 98503
Werner Haleigh A MD - Lacey, WA 98503
Robertson Paul A MD - Lacey, WA 98503
Johnson Cris E MD - Lacey, WA 98503
Vanden Berg Robert D MD - Lacey, WA 98503
Griffith III Harry S MD - Lacey, WA 98503
Smith Ronald P MD - Lacey, WA 98503
Sylwester Patricia MD - Lacey, WA 98503
Idalis Cosmetic Laser & Vein - Lacey, WA 98503
Mihalcea Ana Maria MD - Lacey, WA 98503
Addictions Recovery Center - Lacey, WA 98503
Fairbrook David L MD - Lacey, WA 98503
Lacey Multi Specialty Clinic LLC - Lacey, WA 98503
Mary Kouri Md - Lacey, WA 98503
Huard Bernadette MD - Lacey, WA 98503
Sui David MD - Lacey, WA 98503
|
The company Providence Regional Cancer provides B2C services in the form of Doctors from its single location in Washington.
1 to 4 employees work for Providence Regional Cancer, and the business now earns $10.000.000 to $19.9999.999 per annum.
Providence Regional Cancer was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Providence Regional Cancer, please call Buffie Salo, Office Manager with the phone number (360) 754-3934 or visit its single location at 4525 3rd Avenue Se # 200 in Lacey, Washington 98503.
The location of the single location can also be found using the coordinates 47.04552,-122.82585.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.